Prospective, multicenter, randomized phase II trial of the herbal supplement, PC-SPES, and diethylstilbestrol in patients with androgen-independent prostate cancer. [electronic resource]
Producer: 20041007Description: 3705-12 p. digitalISSN:- 0732-183X
- Administration, Oral
- Aged
- Aged, 80 and over
- Androgens -- pharmacology
- Anticoagulants -- administration & dosage
- Antineoplastic Agents, Hormonal -- pharmacology
- Antineoplastic Agents, Phytogenic -- chemistry
- Complementary Therapies -- standards
- Cross-Over Studies
- Diethylstilbestrol -- pharmacology
- Disease Progression
- Drug Contamination
- Drugs, Chinese Herbal -- chemistry
- Estradiol Congeners -- analysis
- Ethinyl Estradiol -- analysis
- Humans
- Male
- Middle Aged
- Prospective Studies
- Prostatic Neoplasms -- drug therapy
- Reproducibility of Results
- Treatment Outcome
- Warfarin -- administration & dosage
No physical items for this record
Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.